NUCLEIC ACID NANOPARTICLES AND USES THEREFOR
    6.
    发明公开
    NUCLEIC ACID NANOPARTICLES AND USES THEREFOR 有权
    NUKLEINSÄURE-NANOTEILCHEN UND IHRE VERWENDUNGSZWECKE

    公开(公告)号:EP2162117A2

    公开(公告)日:2010-03-17

    申请号:EP08756527.1

    申请日:2008-05-30

    申请人: Anterios, Inc.

    摘要: The present invention provides nanoparticle compositions including one or more nucleic acids. The present invention achieves delivery (particularly transdermal delivery) of such nucleic acids without the need for nucleic acid modification, or for use of chemical or mechanical abrasion or disruption of skin.

    摘要翻译: 本发明提供包含一种或多种核酸的纳米颗粒组合物。 本发明实现了这种核酸的递送(特别是透皮递送),而不需要核酸修饰,或者用于化学或机械磨损或皮肤破坏。

    NANOPARTICLE COMPOSITIONS
    7.
    发明公开

    公开(公告)号:EP3572072A1

    公开(公告)日:2019-11-27

    申请号:EP19151722.6

    申请日:2012-01-23

    申请人: Anterios, Inc.

    IPC分类号: A61K9/14 A61P17/10

    摘要: The present invention describes novel nanoparticle compositions, and systems and methods utilizing them for treating disorders and/or conditions associated with the epidermal and/or dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis chromhidrosis, rosacea, hair loss, dermal infection, actinic keratosis, facial wrinkles, muscle contracture, and headache. Methods generally involved administering nanoparticle compositions to the skin.

    DEMONSTRABLE EFFICACY ACROSS OR WITHIN PATIENT POPULATIONS
    9.
    发明公开
    DEMONSTRABLE EFFICACY ACROSS OR WITHIN PATIENT POPULATIONS 审中-公开
    NACHWEISLICHE WIRKSAMKEITÜBERODER INNERHALB VON PATITENTENPOPULATIONEN

    公开(公告)号:EP3137055A1

    公开(公告)日:2017-03-08

    申请号:EP15785602.2

    申请日:2015-05-01

    申请人: Anterios, Inc.

    发明人: EDELSON, Jonathan

    IPC分类号: A61K9/00

    摘要: The present invention provides methods for improving observed or determined efficacy by administration of agents to more severely diseased subjects, as contrasted with less severely diseased subjects. The present disclosure specifically demonstrates that, with respect to treatment of certain skin conditions, and particularly conditions associated with dysregulated and/or diseased skin cells, administration to more severely diseased subjects improves observed or determined efficacy.

    摘要翻译: 本发明提供了通过向较严重疾病的受试者施用药剂来提高观察到或确定的功效的方法,与较不严重的患病对象相比。 本公开具体地表明,关于治疗某些皮肤状况,特别是与失调和/或患病皮肤细胞相关的病症,给予更严重疾病的受试者改善观察或确定的疗效。

    NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
    10.
    发明公开
    NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR 审中-公开
    NANOPARTIKELZUSAMMENSETZUNGEN,FORMULIERUNGEN DARAUS UND VERWENDUNG

    公开(公告)号:EP2667859A2

    公开(公告)日:2013-12-04

    申请号:EP12701658.2

    申请日:2012-01-23

    申请人: Anterios, Inc.

    IPC分类号: A61K9/51

    摘要: The present invention describes novel nanoparticle compositions, and systems and methods utilizing them for treating disorders and/or conditions. Methods generally involve administering nanoparticle compositions (e.g., nanoparticle compositions comprising at least one known therapeutic agent and/or independently active biologically active agent; and/or empty nanoparticle compositions) to a subject in need thereof.

    摘要翻译: 本发明描述了新型纳米颗粒组合物,以及利用它们用于治疗疾病和/或病症的系统和方法。 方法通常涉及向有需要的受试者施用纳米颗粒组合物(例如,包含至少一种已知的治疗剂和/或独立活性的生物活性剂的纳米颗粒组合物和/或空的纳米颗粒组合物)。